Logo image
Sign in
Back
PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE OR MEDICAL THERAPY FOR STROKE PREVENTION: A META-ANALYSIS OF RANDOMIZED TRIALS
Journal article   Peer reviewed

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE OR MEDICAL THERAPY FOR STROKE PREVENTION: A META-ANALYSIS OF RANDOMIZED TRIALS

Khagendra Dahal, Adil Yousuf, Magdy Hanna, Sharan Sharma, Jharendra Rijal, Hussam Watti, Nelson Telles Garcia, Augustine Njoku, Juyong Lee, Pavan Katikaneni, …
Journal of the American College of Cardiology, Vol.71(11), pp.A1236-A1236
03/10/2018
DOI: https://doi.org/10.1016/S0735-1097(18)31777-7

Abstract

Cardiac arrhythmia Stroke Thromboembolism
Ischemic stroke (IS), transient ischemic attack (TIA), a composite of IS, TIA and systemic thromboembolism (STE), mortality, major bleeding, atrial fibrillation and procedural complications were the major outcomes. PFOC, compared to MT reduced the risk of ischemic stroke [Odds ratio (OR): 0.38; 95% confidence interval (OR): 0.17-0.88, P=0.03] and the composite outcome of ischemic stroke, TIA and systemic thromboembolism [0.49 (0.24-0.99); P=0.05].

Metrics

1 Record Views

Details